Workflow
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. - HROW
Harrow HealthHarrow Health(US:HROW) Prnewswireยท2025-07-07 19:58

Core Viewpoint - Harrow, Inc. is under investigation for potential securities fraud and unlawful business practices following disappointing financial results for Q1 2025, which led to a significant drop in its stock price [1][2]. Financial Performance - Harrow reported revenue of $47.8 million for Q1 2025, which was below the consensus estimate of $57.0 million [2]. - The company also reported an adjusted EBITDA of -$1.9 million, missing the expected $11.9 million [2]. - Following the announcement of these results, Harrow's stock price decreased by $1.00 per share, or 4.07%, closing at $23.59 per share on May 8, 2025 [2]. Legal Investigation - Pomerantz LLP is investigating claims on behalf of Harrow investors regarding possible securities fraud or other unlawful business practices by the company and its officers or directors [1]. - The Pomerantz Firm has a long history in corporate and securities class litigation, having recovered significant damages for victims of securities fraud and corporate misconduct [3].